SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001999371-24-001795
Filing Date
2024-02-09
Accepted
2024-02-09 16:18:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SC 13D gsk_sc13da-020924.htm SC 13D/A 83760
  Complete submission text file 0001999371-24-001795.txt   85841
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GSK plc (Filed by) CIK: 0001131399 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Subject) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-91734 | Film No.: 24615236
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)